British drugmaker AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations related to acid-reflux medicine Nexium and heartburn drug Prilosec in the United States.

(Reporting by Eva Mathews in Bengaluru; Editing by Dhanya Ann Thoppil)